✦ LIBER ✦

Acyclovir-resistant herpes simplex virus treated with intravenous foscarnet and topical cidofovir

Book ID: 116587526
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 41 KB
Volume: 64
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2010.09.474

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chronic hypertrophic acyclovir-resistant

Chronic hypertrophic acyclovir-resistant genital herpes treated with topical cidofovir and with topical foscarnet at recurrence in an HIV-positive man

✍ M Ghislanzoni; M Cusini; R Zerboni; E Alessi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Treatment of an acyclovir and foscarnet-

Treatment of an acyclovir and foscarnet-resistant herpes simplex virus infection with cidofovir in a child after an unrelated bone marrow transplant

✍ Blot, N; Schneider, P; Young, P; Janvresse, C; Dehesdin, D; Tron, P; Vannier, J 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 80 KB

Dual infection with polyomavirus BK and

Dual infection with polyomavirus BK and acyclovir-resistant herpes simplex virus successfully treated with cidofovir in a bone marrow transplant recipient

✍ G. Andrei; P. Fiten; P. Goubau; H. Van Landuyt; B. Gordts; D. Selleslag; E. De C 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

The in vitro activity of cidofovir again

The in vitro activity of cidofovir against acyclovir-resistant and foscarnet-resistant herpes simplex virus (HSV) isolates: S. Safrin, E. Abarbarchuk, E. Palacios. The Herpes Virus Research Laboratory, San Francisco General Hospital, San Francisco CA

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Successful treatment of aciclovir and fo

Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1

✍ Anne-Sophie Lascaux; Eric Caumes; Claire Deback; Giovanna Melica; Dominique Chal 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

## Abstract Aciclovir (ACV)‐resistant __Herpes simplex virus__ type‐2 (HSV‐2) infections are observed commonly in patients also infected with HIV‐1. The use of foscarnet (FOS) in these patients may also lead to resistance. This situation can become a difficult therapeutic challenge. Four cases of p

Efficacies of Topical Formulations of Fo

Efficacies of Topical Formulations of Foscarnet and Acyclovir and of 5-Percent Acyclovir Ointment (Zovirax) in a Murine Model of Cutaneous Herpes Simplex Virus Type 1 Infection

✍ Piret, J.; Desormeaux, A.; Gourde, P.; Juhasz, J.; Bergeron, M. G. 📂 Article 📅 2000 🏛 American Society for Microbiology 🌐 English ⚖ 120 KB